Targeted therapies in bladder cancer: signaling pathways, applications, and challenges

Abstract Bladder cancer (BC) is one of the most prevalent malignancies in men. Understanding molecular characteristics via studying signaling pathways has made tremendous breakthroughs in BC therapies. Thus, targeted therapies including immune checkpoint inhibitors (ICIs), antibody–drug conjugates (...

Full description

Bibliographic Details
Published in:	MedComm
Main Authors:	Mei Peng, Xuetong Chu, Yan Peng, Duo Li, Zhirong Zhang, Weifan Wang, Xiaochen Zhou, Di Xiao, Xiaoping Yang
Format:	Article
Language:	English
Published:	Wiley 2023-12-01
Subjects:	ADCs bladder cancer CSCs ICIs metabolism TKIs
Online Access:	https://doi.org/10.1002/mco2.455

Similar Items

Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer
by: Macus Hao-Ran Bao, et al.
Published: (2021-07-01)

Editorial: Hepatocellular carcinoma: novel treatment strategies, volume III
by: Fan Feng, et al.
Published: (2025-09-01)

Recent Advancements of Monotherapy, Combination, and Sequential Treatment of EGFR/ALK-TKIs and ICIs in Non–Small Cell Lung Cancer
by: Dehua Liao, et al.
Published: (2022-06-01)

HBV reactivation and its effect on survival in HBV-related hepatocarcinoma patients undergoing transarterial chemoembolization combined with tyrosine kinase inhibitors plus immune checkpoint inhibitors
by: Jiaming Shen, et al.
Published: (2023-05-01)

Combination therapy of TKIs and ICIs for the treatment of anaplastic thyroid carcinoma
by: Xi Zhang, et al.
Published: (2025-05-01)

Anti-cancer activity of Chaga mushroom (Inonotus obliquus) against dog bladder cancer organoids
by: Amira Abugomaa, et al.
Published: (2023-04-01)

Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
by: Zhen Zeng, et al.
Published: (2023-10-01)

ADCs and TCE in SCLC Therapy: The Beginning of a New Era?
by: Paola Muscolino, et al.
Published: (2025-04-01)

Immunotherapy and radiotherapy for older patients with invasive bladder cancer unfit for surgery or chemotherapy: practical proposal by the international geriatric radiotherapy group
by: Nam Phong Nguyen, et al.
Published: (2024-07-01)

Transcriptomic insights into UTUC: role of inflammatory fibrosis and potential for personalized treatment
by: Keqiang Li, et al.
Published: (2024-01-01)

The cuproptosis-associated 11 gene signature as a predictor for outcomes and response to Bacillus Calmette-Guerin and immune checkpoint inhibitor therapies in bladder carcinoma
by: Huiyang Yuan, et al.
Published: (2023-05-01)

The Antiasthma Medication Ciclesonide Suppresses Breast Cancer Stem Cells through Inhibition of the Glucocorticoid Receptor Signaling-Dependent YAP Pathway
by: Su-Lim Kim, et al.
Published: (2020-12-01)

Cholesterol and Mevalonate: Two Metabolites Involved in Breast Cancer Progression and Drug Resistance through the ERRα Pathway
by: Matteo Brindisi, et al.
Published: (2020-07-01)

Microvascular rarefaction caused by the NOTCH signaling pathway is a key cause of TKI-apatinib-induced hypertension and cardiac damage
by: WenJuan Wang, et al.
Published: (2024-02-01)

Impact of HER2 Expression on the Prognosis of Muscle-Invasive Bladder Cancer Patients Treated with Bladder-Preservation Comprehensive Therapy
by: Yatong Chen, et al.
Published: (2025-01-01)

Stearoyl CoA desaturase inhibition can effectively induce apoptosis in bladder cancer stem cells
by: Yuchen Li, et al.
Published: (2024-10-01)

Combination immunotherapy in hepatocellular carcinoma: synergies among immune checkpoints, TKIs, and chemotherapy
by: Suoyi Dai, et al.
Published: (2025-09-01)

Antibody-drug conjugates in urinary tumors: clinical application, challenge, and perspectives
by: Keqiang Li, et al.
Published: (2023-12-01)

Update on immune‐based therapy strategies targeting cancer stem cells
by: Amirhossein Izadpanah, et al.
Published: (2023-09-01)

Identification of a novel combination treatment strategy in clear cell renal cell carcinoma stem cells with shikonin and ipilimumab
by: Chen Lyu, et al.
Published: (2023-08-01)

Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day
by: Brigida Anna Maiorano, et al.
Published: (2022-02-01)

EGFR-TKIs resistance via EGFR-independent signaling pathways
by: Qian Liu, et al.
Published: (2018-02-01)

Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics
by: Mia C. Borlongan, et al.
Published: (2023-05-01)

Nephrotoxicity of targeted therapy used to treat lung cancer
by: Qiuling Li, et al.
Published: (2024-07-01)

Significance of CD133 Expression in Invasive Ductal Carcinoma of the Breast
by: Nagwa Abd El-Sadek Ahmed, et al.
Published: (2022-02-01)

Evaluation of EGFR-TKIs and ICIs treatment stratification in non-small cell lung cancer using an encrypted multidimensional radiomics approach
by: Xingping Zhang, et al.
Published: (2025-01-01)

IFIT3 accelerates the progression of head and neck squamous cell carcinoma by targeting PD-L1 to activate PI3K/AKT signaling pathway
by: Peng Liu, et al.
Published: (2024-01-01)

Development a hyaluronic acid ion-pairing liposomal nanoparticle for enhancing anti-glioma efficacy by modulating glioma microenvironment
by: Liuqing Yang, et al.
Published: (2018-01-01)

Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
by: Yanlong Zhang, et al.
Published: (2023-02-01)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges
by: Hao-Tian Liu, et al.
Published: (2021-10-01)

Structural modification of resveratrol analogue exhibits anticancer activity against lung cancer stem cells via suppression of Akt signaling pathway
by: Sunisa Thongsom, et al.
Published: (2023-06-01)

Targeting ferroptosis in cancer stem cells: A novel strategy to improve cancer treatment
by: Luyao Wang, et al.
Published: (2025-11-01)

Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production
by: Marco Fiorillo, et al.
Published: (2020-06-01)

The Flick of a Switch: Conferring Survival Advantage to Breast Cancer Stem Cells Through Metabolic Plasticity
by: Hayley R. Walsh, et al.
Published: (2019-08-01)

RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2-positive locally advanced muscle-invasive urothelial bladder cancer: a multi-center phase Ib/II study (HOPE-03)
by: Feng Wen, et al.
Published: (2024-01-01)

Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment
by: Mahdie Rahban, et al.
Published: (2024-01-01)

Shenqi Fuzheng injection restores the sensitivity to gefitinib in non-small cell lung cancer by inhibiting the IL-22/STAT3/AKT pathway
by: Jiali Wang, et al.
Published: (2024-12-01)

Antibody-drug conjugates as game changers in bladder cancer: current progress and future directions
by: Fei Zhang, et al.
Published: (2025-05-01)

Cancer stem cell biomarkers: critical roles, challenges, clinical applications and perspectives in cancer therapy
by: Elham Bahrami Salehloo, et al.
Published: (2022-05-01)

Detection of cancer stem cell in invasive ductal carcinoma of breast using CD44marker
by: Teeba Khalid Hadi, et al.
Published: (2014-09-01)